Capital Fund Management (CFM)
DGX icon

Capital Fund Management (CFM)’s Quest Diagnostics DGX Stock Holding History

Capital Fund Management (CFM)’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,000
Closed -$2.21M – 2029
2023
Q4 		$2.21M Buy
+16,000
New +$2.1M 0.01% 1487
2022
Q2 		– Sell
-40,000
Closed -$5.47M – 1478
2022
Q1 		$5.47M Buy
40,000
+24,600
+160% +$3.43M 0.04% 539
2021
Q4 		$2.66M Sell
15,400
-29,500
-66% -$4.49M 0.02% 909
2021
Q3 		$6.52M Buy
+44,900
New +$6.57M 0.05% 495
2021
Q2 		– Sell
-36,600
Closed -$4.7M – 1477
2021
Q1 		$4.7M Buy
36,600
+26,000
+245% +$3.2M 0.05% 447
2020
Q4 		$1.26M Buy
+10,600
New +$1.29M 0.01% 923
2020
Q1 		– Sell
-6,800
Closed -$726K – 1642
2019
Q4 		$726K Sell
6,800
-17,100
-72% -$1.78M 0.01% 1231
2019
Q3 		$2.56M Buy
23,900
+11,700
+96% +$1.2M 0.02% 715
2019
Q2 		$1.24M Buy
+12,200
New +$1.17M 0.01% 949
2017
Q4 		– Sell
-3,400
Closed -$318K – 1820
2017
Q3 		$318K Buy
+3,400
New +$361K ﹤0.01% 1310
2016
Q4 		– Sell
-3,500
Closed -$296K – 1686
2016
Q3 		$296K Buy
+3,500
New +$294K ﹤0.01% 1379
2015
Q3 		– Sell
-8,900
Closed -$645K – 1457
2015
Q2 		$645K Sell
8,900
-3,400
-28% -$251K 0.01% 986
2015
Q1 		$945K Buy
+12,300
New +$881K 0.01% 802

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Capital Fund Management (CFM)'s DGX Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in Quest Diagnostics (DGX) in Q1 2026: 26,563 shares worth $5.21M. The stake represents 0.02% of the portfolio and ranks #874 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in DGX as recently as Q3 2025.

Capital Fund Management (CFM) first reported a position in DGX in Q2 2013 and has held it in 30 quarters since. The position peaked at $35.8M in Q4 2017. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Capital Fund Management (CFM) held 26,563 shares of Quest Diagnostics worth $5.21M as of Q1 2026.
  • Quest Diagnostics was a new Capital Fund Management (CFM) position in Q1 2026.
  • Quest Diagnostics made up 0.02% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #874 holding.
  • Capital Fund Management (CFM) first reported a position in Quest Diagnostics in Q2 2013 and has held it in 30 quarters since.
  • Capital Fund Management (CFM)'s Quest Diagnostics position peaked at $35.8M in Q4 2017.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.